, Singapore
171 views

OUE Lippo Healthcare reverses losses in 2021

The company's yearly earnings came in at $111m, compared to a loss of $98.7m in 2020.

Pan-Asian group OUE Lippo Healthcare has revealed its financial statements for 2021.

The group recorded a net profit of $111m for the year ended 31 December 2021. The net profit included a one-off gain of $110m from the completion of the shareholder loan conversion. Excluding the one-off gain, the group made a net profit of $976,000.

The revenue came from the setting up of strategic divisions, offering products and services and are managed separately because they require different technology and marketing strategies. These are healthcare operations, healthcare assets, development of medical facilities, healthcare-related assets and integrated mixed-use projects. It includes the 12 nursing homes in Japan, as well as revenue from the pharmaceutical distribution business and the Wuxi Lippo Xi Nan hospital in China.

However, OUE Lippo Healthcare will be divesting its 12 nursing homes to First REIT, which will increase the group's interest to 36.4%. The financial performance of First REIT will be consolidated into the group's results post-completion of the transaction.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.